Evidence map›Paper›PMID 32187105›Full record

ArticleMedical care2020

Strategy Configurations Directly Linked to Higher Hepatitis C Virus Treatment Starts: An Applied Use of Configurational Comparative Methods.

Vera Yakovchenko, Edward J Miech, Matthew J Chinman, Maggie Chartier, Rachel Gonzalez, JoAnn E Kirchner, Timothy R Morgan, Angela Park, Byron J Powell, Enola K Proctor and 3 more

Abstract read
In one paragraph

Article in Medical care, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Vera YakovchenkoDepartment of Veterans Affairs, Center for Healthcare Organization and Implementation Research, Edith Norse Rogers Memorial VA Hospital, VA BridgeQUERI, Bedford, MA.
Edward J MiechDepartment of Veterans Affairs, Roudebush VA Medical Center, HSR&D Center for Health Information & Communication, VA PRIS-M QUERI.
Matthew J ChinmanDepartment of Veterans Affairs, Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System.
Maggie ChartierHIV, Hepatitis and Related Conditions Programs, Office of Specialty Care Services, Veterans Health Administration, Washington, DC.
Rachel GonzalezDepartment of Veterans Affairs, Gastroenterology Section, VA Long Beach Healthcare System, Long Beach, CA.
JoAnn E KirchnerDepartment of Veterans Affairs, HSR&D and Behavioral Health QUERI, Central Arkansas Veterans Healthcare System, Little Rock, AR.
Timothy R MorganDepartment of Veterans Affairs, Gastroenterology Section, VA Long Beach Healthcare System, Long Beach, CA.
Angela ParkOffice of Healthcare Transformation, Veterans Engineering Resource Center, Washington, DC.
Byron J PowellBrown School, Washington University in St. Louis, St. Louis, MO.
Enola K ProctorBrown School, Washington University in St. Louis, St. Louis, MO.
David RossHIV, Hepatitis and Related Conditions Programs, Office of Specialty Care Services, Veterans Health Administration, Washington, DC.
Thomas J WaltzDepartment of Psychology, Eastern Michigan University, Ypsilanti.
Shari S RogalDepartment of Veterans Affairs, Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System.

Funding

Intramural VA VA999999
6 · The paper itself

Abstract

backgroundThe Department of Veterans Affairs (VA) cares for more patients with hepatitis C virus (HCV) than any other US health care system. We tracked the implementation strategies that VA sites used to implement highly effective new treatments for HCV with the aim of uncovering how combinations of implementation strategies influenced the uptake of the HCV treatment innovation. We applied Configurational Comparative Methods (CCMs) to uncover causal dependencies and identify difference-making strategy configurations, and to distinguish higher from lower HCV treating sites.

methodsWe surveyed providers to assess VA sites' use of 73 implementation strategies to promote HCV treatment in the fiscal year 2015. CCMs were used to identify strategy configurations that uniquely distinguished higher HCV from lower HCV treating sites.

resultsFrom the 73 possible implementation strategies, CCMs identified 5 distinct strategy configurations, or "solution paths." These were comprised of 10 individual strategies that collectively explained 80% of the sites with higher HCV treatment starts with 100% consistency. Using any one of the following 5 solution paths was sufficient to produce higher treatment starts: (1) technical assistance; (2) engaging in a learning collaborative AND designating leaders; (3) site visits AND outreach to patients to promote uptake and adherence; (4) developing resource sharing agreements AND an implementation blueprint; OR (5) creating new clinical teams AND sharing quality improvement knowledge with other sites AND engaging patients. There was equifinality in that the presence of any one of the 5 solution paths was sufficient for higher treatment starts.

conclusionsFive strategy configurations distinguished higher HCV from lower HCV treating sites with 100% consistency. CCMs represent a methodological advancement that can help inform high-yield implementation strategy selection and increase the efficiency and effectiveness of future implementation efforts.

Indexed as

Critical PathwaysMedication AdherenceAntiviral AgentsHepatitis CHumansProgram EvaluationUnited StatesUnited States Department of Veterans AffairsVeterans Health ServicesAntiviral Agents

Identifiers

PMID32187105
PMCPMC7161717

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.